Lilly Reports Strong Fourth-Quarter 2023 Financial Results and Provides 2024 Guidance | Eli Lilly and Company - Investors | Eli Lilly and Company
2/6/2024
Lilly Reports Strong Fourth-Quarter 2023 Financial Results and Provides 2024 Guidance | Eli Lilly and Company Investors | Eli Lilly and CompanyAnalyst says these are the 'critical' next steps for Eli Lilly Yahoo FinanceEli Lilly results blow past estimates on strong Zepbound launch, surging Mounjaro revenue CNBCEli Lilly Stock Rises on Earnings Beat, Obesity Drug Sales Barron'sEii Lilly sold $176 million of Zepbound, Q4 report says Quartz...
Original
Categories: Earnings | Financial | Health | Launch | Obesity | Science | Space | Stock
Tags: beat | company | drug | earnings | financial | guidance | investors | launch | million | report | reports | results | rises | sold | stock | strong